
Is ESG Already Central to Healthtech Strategy?

GenSearch has signed the Charte de la Diversité, a national charter in France that encourages organisations to take practical action against discrimination and promote inclusion across all areas of employment. This commitment reflects our intention to build fairer recruitment processes and contribute to more representative leadership in the life sciences sector.
Launched in 2004, the Charte de la Diversité brings together organisations that voluntarily commit to advancing diversity in the workplace. Signatories work to ensure:
Over 5,000 companies in France have signed the Charter to date, spanning a wide range of industries and sectors.
In executive search for the life sciences industry, inclusive hiring is essential. Signing the Charte de la Diversité strengthens GenSearch’s alignment with best practices in:
Diversity in leadership leads to more robust decision-making, increased innovation, and stronger organisational performance — all critical factors in healthcare and science.
Heiko Bruhn from GenSearch will be joining at the 5th Annual European HealthTech CEO Forum on February 27, 2024, at the Hilton Zurich Airport Hotel.
Read more “SACHS 5th Annual European HealthTech CEO Forum (#Sachs_EHTF)”Heiko Bruhn will be present at the next SACH’s CEO Forum taking place on 1-2 March 2023 in Zurich.
Read more “16th Annual European Life Sciences CEO Forum (ELSF)”Heiko Bruhn will be moderating a round table entitled “Attract & retain talents” at the Swiss Biotech Day.
Read more “Swiss Biotech Day 2022”